MYC suppresses cancer metastasis by direct transcriptional silencing of α v and β 3 integrin subunits

Nature Cell Biology

Volumn 14, Issue 6, 2012, Pages 567-574

  Liu, Hong ^a,d   Radisky, Derek C ^b   Yang, Dun ^a   Xu, Ren ^c   Radisky, Evette S ^b   Bissell, Mina J ^c   Bishop, J Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d EUREKA THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD51 ANTIGEN; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; GENE SILENCING; HUMANS; INTEGRIN ALPHA5; INTEGRIN BETA3; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 84861592850     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2491     Document Type: Article

References (50)

1. Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699 (2000). (Pubitemid 32037520)
2. Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2, 764-776 (2002). (Pubitemid 37328911)
3. Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell Biol. 19, 1-11 (1999). (Pubitemid 29018404)
4. Kuttler, F. & Mai, S. c-Myc, genomic instability and disease. Genome Dyn. 1, 171-190 (2006).
5. Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84, 81-154 (2002). (Pubitemid 34188195)
6. Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635-645 (2005). (Pubitemid 41081267)
7. Meyer, N. & Penn, L. Z. Re-ecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990 (2008).
8. Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016 (1999). (Pubitemid 29276540)
9. Alitalo, K. & Schwab, M. Oncogene ampli-cation in tumor cells. Adv. Cancer Res. 47, 235-281 (1986).
10. Boxer, R. B., Jang, J. W., Sintasath, L. & Chodosh, L. A. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6, 577-586 (2004). (Pubitemid 40017701)
11. Liao, D. J. & Dickson, R. B. c-Myc in breast cancer. Endocr. Relat. Cancer 7, 143-164 (2000).
12. Pompetti, F. et al. Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J. Cell Biochem. 63, 37-50 (1996). (Pubitemid 26329785)
13. Shiu, R. P., Watson, P. H. & Dubik, D. c-myc oncogene expression in estrogen-dependent and-independent breast cancer. Clin. Chem. 39, 353-355 (1993). (Pubitemid 23069701)
14. D'Cruz, C. M. et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7, 235-239 (2001). (Pubitemid 32148492)
15. Leder, A., Pattengale, P. K., Kuo, A., Stewart, T. A. & Leder, P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45, 485-495 (1986). (Pubitemid 16014971)
16. Sinn, E. et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465-475 (1987). (Pubitemid 18091823)
17. Stewart, T. A., Pattengale, P. K. & Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38, 627-637 (1984). (Pubitemid 15176093)
18. Welm, A. L., Kim, S., Welm, B. E. & Bishop, J. M. MET and MYC cooperate in mammary tumorigenesis. Proc. Natl Acad. Sci. USA 102, 4324-4329 (2005). (Pubitemid 40397110)
19. Frye, M., Gardner, C., Li, E. R., Arnold, I. & Watt, F. M. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793-2808 (2003). (Pubitemid 37069593)
20. Waikel, R. L., Kawachi, Y., Waikel, P. A., Wang, X. J. & Roop, D. R. Deregulated expression of c-Myc depletes epidermal stem cells. Nat. Genet. 28, 165-168 (2001). (Pubitemid 32538063)
21. Guo, W. & Giancotti, F. G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816-826 (2004). (Pubitemid 39336275)
22. Hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91-100 (2002). (Pubitemid 37328796)
23. Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: A dynamic niche in cancer progression. J. Cell Biol. 196, 395-406 (2012).
24. Felding-Habermann, B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20, 203-213 (2003). (Pubitemid 36513225)
25. Mizejewski, G. J. Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222, 124-138 (1999).
26. Gebhardt, A. et al. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J. Cell Biol. 172, 139-149 (2006). (Pubitemid 43042636)
27. De Nigris, F. et al. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of-3-1-integrin in tumour cells. Oncogene 26, 382-394 (2007). (Pubitemid 46122828)
28. Van Golen, C. M., Soules, M. E., Grauman, A. R. & Feldman, E. L. N-Myc overexpression leads to decreased-1 integrin expression and increased apoptosis in human neuroblastoma cells. Oncogene 22, 2664-2673 (2003). (Pubitemid 36605613)
29. Wilson, A. et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747-2763 (2004). (Pubitemid 39507768)
30. Xiao, J., Jethanandani, P., Ziober, B. L. & Kramer, R. H. Regulation of-7 integrin expression during muscle differentiation. J. Biol. Chem. 278, 49780-49788 (2003). (Pubitemid 37548811)
31. Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008). (Pubitemid 350309740)
32. Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science 302, 1704-1709 (2003). (Pubitemid 37505725)
33. Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374 (2003). (Pubitemid 37328856)
34. Carman, C. V. & Springer, T. A. Integrin avidity regulation: are changes in af-nity and conformation underemphasized?. Curr. Opin. Cell Biol. 15, 547-556 (2003). (Pubitemid 37176963)
35. Bauer, K., Mierke, C. & Behrens, J. Expression pro-ling reveals genes associated with transendothelial migration of tumor cells: a functional role for-v-3 integrin. Int. J. Cancer 121, 1910-1918 (2007). (Pubitemid 47463153)
36. Wanzel, M., Herold, S. & Eilers, M. Transcriptional repression by Myc. Trends Cell Biol. 13, 146-150 (2003). (Pubitemid 36293787)
37. Small, M. B., Hay, N., Schwab, M. & Bishop, J. M. Neoplastic transformation by the human gene N-myc. Mol. Cell Biol. 7, 1638-1645 (1987). (Pubitemid 17059158)
38. Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223-238 (2003). (Pubitemid 37163836)
39. Jamerson, M. H., Johnson, M. D. & Dickson, R. B. Of mice and Myc: c-Myc and mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 9, 27-37 (2004). (Pubitemid 39137495)
40. Arvanitis, C. & Felsher, D. W. Conditional transgenic models de-ne how MYC initiates and maintains tumorigenesis. Semin. Cancer Biol. 16, 313-317 (2006). (Pubitemid 44311038)
41. Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999). (Pubitemid 29456888)
42. Liu, H., Radisky, D. C. & Bissell, M. J. Proliferation and polarity in breast cancer: untying the Gordian knot. Cell Cycle 4, 646-649 (2005). (Pubitemid 41353842)
43. Liu, H., Radisky, D. C., Wang, F. & Bissell, M. J. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J. Cell Biol. 164, 603-612 (2004). (Pubitemid 38233321)
44. Liu, H. et al. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc. Natl Acad. Sci. USA 103, 4134-4139 (2006).
45. Liapis, H., Flath, A. & Kitazawa, S. Integrin-v-3 expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol. 5, 127-135 (1996). (Pubitemid 26157584)
46. Desgrosellier, J. S. et al. An integrin-v-3-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 15, 1163-1169 (2009).
47. Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256 (2010).
48. Rapp, U. R. et al. MYC is a metastasis gene for non-small-cell lung cancer. PLoS One 4, e6029 (2009).
49. Wolfer, A. et al. MYC regulation of a ̀poor-prognosis' metastatic cancer cell state. Proc. Natl Acad. Sci. USA 107, 3698-3703 (2010).
50. Vita, M. & Henriksson, M. The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16, 318-330 (2006). (Pubitemid 44311040)